Manufacturer record

Karnani pharmaceuticals Pvt ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

5 batches manufactured by Karnani pharmaceuticals Pvt ltd (Uttarakhand) were declared Not of Standard Quality between September 2024 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

5 records linked to Karnani pharmaceuticals Pvt ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
5Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Sep 2024 to Jun 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

5
NSQ batches since 2024
5
Products affected
Assay
Most common failure
Jun 2026
Latest alert

Flagged batches per year

2024 · 32026 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
BENZYL BENZOATEE APPLICATION IP 3172Mfg 2025-12 · Exp 2027-11 The sample does not conform to claim as per IP 2022 in respect to the Assay of Benzyl NenzoateAssay DRUG TESTING LABORATORY BADDIState lab Jun 2026
SANKHA VATI 5g (Ayurvedic) KT-098Mfg 2025-11 · Exp 2028-10 The sample does not conform to Standard Quality in respect of the tests for Total Ash value performed.Other SDTL Govt. of Tripura, AgartalaState lab Jan 2026
Zinc Sulphate 20 mg Dispersible Tablets IP T-16427Mfg 2024-07 · Exp 2026-06 NOT OF STANDARD QUALITY Out of 18 tablets tested, 12 tablets failed to disintegrate within 60 seconds. Hence disintegration test does not comply for Zinc sulphate dispersible tablets as per I.P. 2022.Disintegration State Lab Drugs Control Laboratory, TelanganaState lab Nov 2024
Loperamide Hydrochloride Tablets IP (JKMSCL Hospital Supply) T-16201Mfg 2024-05 · Exp 2026-04 The sample does not conform to IP with respect to the test for Dissolution & AssayAssay Drug Testing Laboratory Srinagar (J&K) vide report on Form 13 bearing No. L/DA/2024-25/1311 Dated: 27.09.2024. (Report attached as Annexure C)State lab Sep 2024
BISACODYL TABLETS I.P. (Bisalax Tablets) T-14996Mfg 2022-12 · Exp 2025-05 Dissolution (Buffer stage), Related substances and Assay of BisacodylAssay CDTL MumbaiCDSCO lab Sep 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.